Results 111 to 120 of about 5,561 (172)

Targeted delivery and controlled release of deferasirox for melanoma therapy. [PDF]

iScience
Su X, Zhao W, Wang L, Song P, Wang X, Jin X, Zhang H.   +6 more
europepmc   +1 more source

Bridging Pharmacokinetics and Pharmacodynamics: A PBPK/PD Model-Based Approach for Deferasirox Dosing in Transfusion-Dependent Thalassemia. [PDF]

Clin Transl Sci
Sakares W, Udomnilobol U, Pan X, Yampayon K, Ekwattanakit S, Viprakasit V, Limwongse C, Srichairatanakool S, Teerawonganan P, Kunsa-Ngiem S, Khaowroongrueng V, Techatanawat I, Prueksaritanont T, Yodsurang V.   +13 more
europepmc   +1 more source

Extracorporeal Blood Purification Therapy to Deal a Deferasirox Induced Life-Threatening Hepatic Encephalopathy in a Septic Child With Sickle-Cell Disease: A Case Report. [PDF]

J Clin Apher
Rossetti E, Cappoli A, Labbadia R, Leone G, Chiusolo F, Tortora F, Martinelli D, Marano M.   +7 more
europepmc   +1 more source

Established and emerging non-cellular therapies in inherited bone marrow failure syndromes. [PDF]

Front Immunol
Janczar S, Urbański B, Ussowicz M, Mlynarski W.   +3 more
europepmc   +1 more source

Coenzyme-based elastomeric adhesive patch as iron ion capturer to regulate iron metabolism for diabetic oral ulcer repair. [PDF]

Bioact Mater
Yang R, Shao J, Zhang Q, Sun Y, Zhao X, Cui C, Liu W.   +6 more
europepmc   +1 more source

Follow-Up of 3-Year Luspatercept Treatment in a Transfused ß-Thalassemia Patient. Bone Marrow: An Undervalued Iron Store. [PDF]

EJHaem
Bleeke M, Niekrens C, Datta S, Grosse R, Longo F, Molwitz I, Fischer R.   +6 more
europepmc   +1 more source

β-thalassemia trait and iron overload: is it time to consider oral iron chelators? Comment on: "A case series of patients with β-thalassemia trait and iron overload: from multifactorial hepcidin suppression to treatment with mini-phlebotomies". [PDF]

Haematologica
Piperno A, Mariani R.
europepmc   +1 more source

Allogeneic hematopoietic cell transplantation rescues congenital red cell aplasia in H syndrome due to <i>SLC29A3</i> mutations. [PDF]

Haematologica
Quigg TC, Kurt BA, Seaver LH, Holsworth AR, Duffner UA.   +4 more
europepmc   +1 more source

Oesophageal <i>mucormycosis</i> managed with antifungal therapy alone with PET/CT for monitoring treatment response: a case report and a review of the literature. [PDF]

Med Mycol Case Rep
Tan EX, Collis B, Holmes N, Lokan J, Grigg A.   +4 more
europepmc   +1 more source

A case report of congenital sideroblastic anemia caused by a novel ALAS2 mutation in conjunction with thalassemia. [PDF]

Ann Hematol
Chen ZX, Yang LY, Wang LT, Chen BY, Liang JL, Liu LL, Yu XH.   +6 more
europepmc   +1 more source